Filter
693
Text search:
candidates
Featured
Recommendations
65
New Publications
176
Language
Document type
No document type
376
Studies & Reports
118
Guidelines
84
Fact sheets
34
Manuals
23
Strategic & Response Plan
23
Resource Platforms
12
Training Material
7
Situation Updates
6
Videos
6
Online Courses
3
Brochures
1
Countries / Regions
India
45
Global
28
Liberia
18
South Africa
17
Nepal
16
Zambia
16
Kenya
14
Sierra Leone
12
Malawi
12
Western and Central Europe
12
Ethiopia
11
Africa
11
Nigeria
10
Tanzania
10
West and Central Africa
10
Myanmar / Burma
9
East and Southern Africa
9
Latin America and the Carribbean
9
Uganda
8
Bangladesh
8
Middle East and North Africa
8
Russia
8
Philippines
7
Syria
7
Rwanda
7
Ghana
6
Haiti
6
Germany
6
Eastern Europe
6
Guinea
5
Congo, Democratic Republic of
5
Cambodia
5
China
5
Senegal
4
USA
4
Zimbabwe
4
South Sudan
4
Namibia
4
Ukraine
4
Brazil
3
Botswana
3
Asia
3
Turkey
2
Thailand
2
Indonesia
2
Mozambique
2
Benin
2
Central African Republic
2
Peru
2
North Macedonia
2
Colombia
2
Madagascar
2
Lesotho
2
Georgia
2
Portugal
2
Burkina Faso
1
Morocco
1
Cameroon
1
Jordan
1
Afghanistan
1
Lebanon
1
Papua New Guinea
1
Argentina
1
Switzerland
1
Hungary
1
Mexico
1
Eastern Europe and Central Asia
1
Paraguay
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Lithuania
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Jamaica
1
France
1
United Kingdom
1
Norway
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
253
Clinical Guidelines
65
Public Health
35
Women & Child Health
22
Key Resources
13
Capacity Building
8
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
COVID-19
111
TB
39
Mental Health
38
Disability
33
HIV
27
Caregiver
27
Ebola
24
Rapid Response
22
NTDs
20
AMR
16
Refugee
13
Conflict
9
Natural Hazards
9
Health Financing Toolbox
8
NCDs
8
Global Health Education
7
Zika
6
Planetary Health
6
Pharmacy
6
Polio
4
Social Ethics
4
Cholera
3
Typhoon
3
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in different languages
Many countries are using the approach of mixing vaccine doses from different manufacturers. What do we know about the safety and efficacy of this approach? What does the evidence tell us about using a fraction of the vaccine dose ? Dr Katherine O’Brien explains in Science in 5 this week.
Closed C
...
As of January 20, 2021 the Covid-19 - living NMA initiative collected 150 RCTs and 36 non-randomised studies of vaccines from the ICTRP. 93 of these trials are recruiting patients.
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in English, French, Spanisch, Arabic, Chinese and Russian
How COVID-19 mRNA Vaccines Work
recommended
COVID-19 mRNA vaccines deliver directions to make a protein that educates our immune system, so it will neutralize the virus in future encounters. The mRNA-containing lipid particles are taken up by specialized immune system cells
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h
...
COVID-19 vaccine market dashboard
recommended
An interactive tool for partners, manufacturers, and countries to follow the developments of the COVID-19 vaccine market with up-to-date information.
As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard – an interactive
...
Adaptable guidance, tools, trainings, and advocacy materials are being developed to support countries in preparing for COVID-19 vaccination. Please visit this page regularly for updates.
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir
...
AstraZeneca-SKBio in South Korea and Serum Institute of India